Clinical trial
Glucagon-like Peptide-1's Effect on Renal Regional Blood Flow and the Renal Function in Patients With Type 2 Diabetes Mellitus
NCT06555146 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glucagon-like Peptide-1's Effect on Renal Regional Blood Flow and the Renal Function in Patients With Type 2 Diabetes Mellitus
- Lead sponsor
- Bispebjerg Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 31, 2024
- Completion date
- March 31, 2025
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type 2, kidney disease, chronic